Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-17

Clinical Trial Update: Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and efficacy of a single administration of Oshadi Oral Insulin in patients with Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oshadi Oral Insulin (insulin)

Snippet

Sponsor: Oshadi Drug Administration | Conditions: Diabetes | Phase 1 | Status: COMPLETED